Dr Stella Tan Li Kar
Academic Qualification
- Doctor of Philosophy (Pharmaceutical Sciences), Taylor's University, Malaysia
- Bachelor of Pharmacy, Taylor's University, Malaysia
Professional Qualification
No records found
Areas of Expertise
- Medical And Health Sciences, Pharmaceutical Technology , Pharmaceutical Technology
- Medical And Health Sciences, Pharmacology, Molecular Pharmacology
Research Interest
- Magnetic Hyperthermia
- Magnetic Targeting
- Formulation & Drug Delivery
Publications
2024
- Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases (ISI-Indexed), Signal transduction and targeted therapy - Article in Journals
- Skin lightening properties of zerumbone cream: A placebo-controlled study (ISI-Indexed), Journal of Cosmetic Dermatology - Article in Journals
2023
- Magnetic-guided targeted delivery of zerumbone/SPION co-loaded in nanostructured lipid carrier into breast cancer cells (ISI-Indexed), Journal of Drug Delivery Science and Technology - Article in Journals
2022
- Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats (ISI-Indexed), Pharmaceutics - Article in Journals
- Emerging Nanotheranostics for 5-Fluorouracil in Cancer Therapy: A Systematic Review on Efficacy, Safety, and Diagnostic Capability (ISI-Indexed), Frontiers in pharmacology - Article in Journals
2021
- Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids (ISI-Indexed), Cancers - Article in Journals
2020
- Resveratrol as a potential broad-spectrum compound for cancer treatment, Progress in Microbes and Molecular Biology - Article in Journals
Research
- Deciphering the Stability, Pharmacokinetics, and Cellular Uptake of Combinatorial Pardaxin-Derived Anticancer Peptides within Natural Killer Cells-Derived Exosome/Liposome Hybrid System for Breast Cancer, Project Leader, 2024 to 2027, National
- Formulation, optimisation, and characterisation of tumor-targeted liposomes for targeted delivery of anticancer peptide D18.13 to breast cancer cells in vitro , Co-researcher, 2024 to 2025, Taylor's University
Awards and Stewardship
No records found
Paper Presented
No records found